Aroa Biosurgery is looking to accelerate its US growth.
Aroa Biosurgery, a New Zealand-headquartered, emerging global leader for tissue regeneration products used in complex wounds and soft tissue repair, has announced the appointment of a highly experienced US-based executive, Brad Adams, to the new position of vice-president, commercial.
Aroa chief executive Brian Ward welcomed the appointment of Adams, who brings 20 years of experience in the strategic sales and marketing of medical devices within the US system.
Prior to his recent role as vice-president, sales at ACell – a Columbia, Maryland-based regenerative medicine company, Adams had more than 15 years within the Smith & Nephew and Johnson & Johnson families of companies, much of it in senior sales and marketing roles.
“Brad joins us as we look to accelerate our US growth. His background in growing and managing sales teams will help us fully leverage last year’s formation of Appulse, our 50% marketing joint venture with Hydrofera,” Ward said.
Appulse recently increased its field sales team by five people to 30 and Aroa opened a new office in San Diego in September to provide further sales support.
Adams is a member of the American College of Healthcare Executives. He holds a masters of health administration (Medical College of Virginia), bachelor of arts with distinction, (Virginia Military Institute) and has undertaken professional courses at Harvard Business School and The Wharton School, University of Pennsylvania.
This is supplied content and not commissioned or paid for by NBR.
